Our contribution adds to this work, showing that the excessive clustered spine stabilization previously observed in the MECP2-duplication syndrome mouse model (Ash et al., 2021) can be normalized in vivo with a pharmacological inhibitor of ERK signaling. The gene discussed is MECP2; the disease is Down syndrome.